Candida spp are opportunistic fungi responsible for a wide range of infections, from superficial mucosal candidiasis to life-threatening invasive candidiasis. The increasing prevalence of Candida infections, coupled with rising antifungal resistance and diagnostic challenges, underscores a critical need for improved understanding of their pathogenesis, more accurate and rapid diagnostic methods, and effective treatment strategies. Advances in molecular biology and immunology have begun to shed light on host-pathogen interactions, virulence factors, and resistance mechanisms. However, gaps remain in early detection, management of resistant strains, and development of novel antifungal agents. Addressing these issues is vital for reducing morbidity, mortality, and healthcare costs associated with Candida infections, especially among immunocompromised populations.
This Research Topic aims to explore the recent advances in understanding, diagnosing, and treating Candida infections. We aim to reveal innovative approaches that improve early detection, elucidate mechanisms of pathogenicity and resistance, and develop more effective, targeted therapies. Addressing these challenges involves integrating multidisciplinary research, from molecular diagnostics and immune responses to antifungal development and clinical management. By fostering collaboration among microbiologists, clinicians and bioinformaticians, this collection seeks to bridge existing knowledge gaps and promote translational research that can inform clinical practice. Ultimately, the goal is to enhance patient outcomes through improved diagnostic tools, personalized treatment regimens, and novel therapeutic options.
This new research topic invites original research articles, reviews, case studies as well as technical reports focused on recent advances in Candida infections. Specific themes include, but are not limited to:
• molecular mechanisms of pathogenesis and resistance,
• novel diagnostic methods,
• innovative antifungal agents and combination therapies,
• host immune responses,
• epidemiology and clinical management.
Contributions should aim to provide insights that can translate into improved clinical outcomes. Manuscripts should be well-structured, scientifically rigorous, and accessible to a multidisciplinary audience. Both experimental and clinical studies are welcome, as are studies addressing global health perspectives on Candida infections.
Candida spp are opportunistic fungi responsible for a wide range of infections, from superficial mucosal candidiasis to life-threatening invasive candidiasis. The increasing prevalence of Candida infections, coupled with rising antifungal resistance and diagnostic challenges, underscores a critical need for improved understanding of their pathogenesis, more accurate and rapid diagnostic methods, and effective treatment strategies. Advances in molecular biology and immunology have begun to shed light on host-pathogen interactions, virulence factors, and resistance mechanisms. However, gaps remain in early detection, management of resistant strains, and development of novel antifungal agents. Addressing these issues is vital for reducing morbidity, mortality, and healthcare costs associated with Candida infections, especially among immunocompromised populations.
This Research Topic aims to explore the recent advances in understanding, diagnosing, and treating Candida infections. We aim to reveal innovative approaches that improve early detection, elucidate mechanisms of pathogenicity and resistance, and develop more effective, targeted therapies. Addressing these challenges involves integrating multidisciplinary research, from molecular diagnostics and immune responses to antifungal development and clinical management. By fostering collaboration among microbiologists, clinicians and bioinformaticians, this collection seeks to bridge existing knowledge gaps and promote translational research that can inform clinical practice. Ultimately, the goal is to enhance patient outcomes through improved diagnostic tools, personalized treatment regimens, and novel therapeutic options.
This new research topic invites original research articles, reviews, case studies as well as technical reports focused on recent advances in Candida infections. Specific themes include, but are not limited to:
• molecular mechanisms of pathogenesis and resistance,
• novel diagnostic methods,
• innovative antifungal agents and combination therapies,
• host immune responses,
• epidemiology and clinical management.
Contributions should aim to provide insights that can translate into improved clinical outcomes. Manuscripts should be well-structured, scientifically rigorous, and accessible to a multidisciplinary audience. Both experimental and clinical studies are welcome, as are studies addressing global health perspectives on Candida infections.